Raptiva Lawsuits Cause of Controversy

Plaque Psoriasis Symptoms in the News

Raptiva Lawsuits Cause of Controversy
Filed under: plaque psoriasis symptoms

According to the FDA, the patients were between the ages of 47 and 73 and were using Raptiva to treat moderate to severe plaque psoriasis. Two of the patients with confirmed PML died and one patient with possible PML also died. One patient with …
Source

 

Biocon gets approval to sell psoriasis drug in India
Filed under: plaque psoriasis symptoms

Itolizumab is a therapy to treat persistent plaque psorisis, and it is the second biologic — a drug that works by implementing a biological process in the body — developed at the company's headquarters in Bangalore, according to the Business Standard.
Source

 

Celgene Upbeat About 2013
Filed under: plaque psoriasis symptoms

Recently, Celgene presented encouraging data from two phase III studies (ESTEEM 1 and 2), evaluating apremilast in patients suffering from moderate-to-severe chronic plaque psoriasis. Celgene expects to seek FDA approval for the indication on the basis …
Source

 

More Plaque Psoriasis Symptoms Information…